Skip to content

Clinical trials

Terminated Phase 2/3 Lung Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2/3 Status: Terminated Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20051
20061
20071
20115

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated9

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Auron Healthcare GmbH1
Bioven Sdn. Bhd.1
European Organisation for Research and Treatment of Cancer - EORTC1
M.D. Anderson Cancer Center1
Synta Pharmaceuticals Corp.1
The University of Texas Health Science Center at San Antonio1
University of California, San Francisco1
University of Wisconsin, Madison1
Washington University School of Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms9
Carcinoma, Non-Small-Cell Lung3
Prostatic Neoplasms3
Breast Neoplasms2
Colorectal Neoplasms2
Esophageal Neoplasms2
Adenocarcinoma of Lung1
Adenocarcinoma, Bronchiolo-Alveolar1
Adenoma, Islet Cell1
Bone Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.